|
State Department |
|
|
Programme |
|
|
Sub Programme |
|
|
Allocation: |
KES 22,520,960.00 (R) |
Key Performance Indicators (Targets)
Key Output |
KPI |
Target Yr (2024) |
Target Yr (2025) |
Target Yr (2026) |
|---|---|---|---|---|
Disease Control Services |
No. of patients receiving Anti- retroviral Therapy (ART) supplies (millions) |
1.3 |
1.3 |
1.3 |
Disease Control Services |
No. of people receiving Artemisinin Combination Therapy (ACT) (millions) |
7.0 |
7.5 |
8.0 |
Disease Control Services |
% of TB patients treated |
100 |
100 |
100 |
Disease Control Services
No. of patients receiving Anti- retroviral Therapy (ART) supplies (millions)
2024
1.3
2025
1.3
2026
1.3
Disease Control Services
No. of people receiving Artemisinin Combination Therapy (ACT) (millions)
2024
7.0
2025
7.5
2026
8.0
Disease Control Services
% of TB patients treated
2024
100
2025
100
2026
100
Previous Year Allocations
Num |
Year |
Total |
|---|---|---|
1 |
KES 23,922,425.00 |
|
2 |
KES 22,520,960.00 |
|
3 |
KES 11,101,456.00 |
|
4 |
KES 6,099,626.00 |
|
5 |
KES 6,269,135.00 |
User Uploads
No. of PPP projects approved: 12
KES 86,537,104.00
KES 83,748,179.00
(2024)
Funds disbursed to MDAs as a % of the external resources mobilized: 100
KES 204,365,629.00
(2024)
% completion of construction: 100
KES 956,940,814.00
(2024)